Skip to main content
. 2021 Aug 19;15(4):213. doi: 10.3892/mco.2021.2375

Table I.

Gene mutational profile in a patient with lung adenocarcinoma by next-generation sequencing of DNA obtained from surgical specimens.

Genes Mutation sites Frequency, % Amplification (copy no.)
HER2 F616La 1.46 11
ErbB4 N280I 24.41  
GATA1 S12P 1.17  
GNAS T386P 1.82  
KIT M1R 2.58  
KIT A621S 21.79  
MSH3 K281fs 1.73  
TP53 G154V 33.57  
VEGFA L139R 1.08  

aThis mutation is not a classic activating mutation and unlikely to be responsible for the responsiveness to HER2-targeted therapy.